Sayfa yüklenirken bir hata oluştu.
Teknik ekibimiz bilgilendirildi, ancak sorunun devam etmesi durumunda lütfen e-posta destek widget ile bize ulaşın.
| Metrics | Range | Conclusion |
|---|---|---|
| Selected LTM EBIT Multiple | -27,1x - -29,9x | -28,5x |
| Selected Fwd EBIT Multiple | 78,3x - 86,6x | 82,4x |
| Fair Value | ¥4,57 - ¥5,48 | ¥5,03 |
| Upside | -6,1% - 12,6% | 3,3% |
| Benchmarks | Ticker | Full Ticker |
| TECON BIOLOGY Co.LTD | 2100 | SZSE:002100 |
| Dongrui Food Group Co., Ltd. | 1201 | SZSE:001201 |
| Shandong Bailong Chuangyuan Bio-Tech Co., Ltd. | 605016 | SHSE:605016 |
| Hunan New Wellful Co.,Ltd. | 600975 | SHSE:600975 |
| Tangrenshen Group Co., Ltd | 2567 | SZSE:002567 |
| Shanghai Xuerong Biotechnology Co.,Ltd. | 300511 | SZSE:300511 |
| - | - | - |
| Select LTM EBIT Multiple | |||||||
| Benchmark Companies | |||||||
| 2100 | 1201 | 605016 | 600975 | 2567 | 300511 | ||
| SZSE:002100 | SZSE:001201 | SHSE:605016 | SHSE:600975 | SZSE:002567 | SZSE:300511 | ||
| Historical EBIT Growth | |||||||
| 5Y CAGR | NM- | NM- | 25.6% | 36.3% | NM- | NM- | |
| 3Y CAGR | NM- | NM- | 38.0% | NM- | NM- | NM- | |
| Latest Twelve Months | -10.8% | 15.0% | 49.3% | 134.2% | 90.6% | -222.4% | |
| Historical EBIT Profit Margin | |||||||
| 5 Year Average Margin | 3.6% | 3.8% | 20.9% | -2.1% | 0.7% | 2.0% | |
| Prior Fiscal Year | 2.2% | 6.9% | 22.3% | -17.2% | 1.6% | 2.3% | |
| Latest Fiscal Year | -6.8% | -42.9% | 25.1% | 4.7% | -4.4% | -4.5% | |
| Latest Twelve Months | -2.3% | -15.0% | 25.1% | 4.7% | -0.2% | -6.9% | |
| Current Trading Multiples | |||||||
| EV / LTM Revenue | 0.71x | 4.15x | 4.68x | 2.07x | 0.56x | 1.98x | |
| EV / LTM EBITDA | 63.0x | 34.3x | 16.2x | 18.5x | 14.4x | 29.8x | |
| EV / LTM EBIT | -31.5x | -27.6x | 18.7x | 44.1x | -271.7x | -28.8x | |
| Low | Mid | High | |||||
| Benchmark EV / LTM EBIT | -271.7x | -27.6x | 44.1x | ||||
| Historical EV / LTM EBIT | -3060.3x | -74.9x | 21.3x | ||||
| Selected EV / LTM EBIT | -27.1x | -28.5x | -29.9x | ||||
| (x) LTM EBIT | (155) | (155) | (155) | ||||
| (=) Implied Enterprise Value | 4,202 | 4,423 | 4,644 | ||||
| (-) Non-shareholder Claims * | (2,023) | (2,023) | (2,023) | ||||
| (=) Equity Value | 2,179 | 2,400 | 2,621 | ||||
| (/) Shares Outstanding | 498.8 | 498.8 | 498.8 | ||||
| Implied Value Range | 4.37 | 4.81 | 5.25 | ||||
| FX Rate: CNY/CNY | 1.0 | 1.0 | 1.0 | Market Price | |||
| Implied Value Range (Trading Cur) | 4.37 | 4.81 | 5.25 | 4.87 | |||
| Upside / (Downside) | -10.3% | -1.2% | 7.9% | ||||
| Equity Waterfall | |||||||
| Benchmark Companies | |||||||
| (in millions) | 2100 | 1201 | 605016 | 600975 | 2567 | 300511 | |
| Enterprise Value | 12,352 | 5,336 | 5,389 | 14,615 | 13,001 | 4,453 | |
| (+) Cash & Short Term Investments | 3,661 | 699 | 409 | 1,170 | 1,910 | 193 | |
| (+) Investments & Other | 34 | 38 | 0 | 359 | 157 | 16 | |
| (-) Debt | (5,747) | (2,266) | (73) | (7,919) | (7,285) | (2,341) | |
| (-) Other Liabilities | (1,535) | (8) | 0 | (191) | (434) | 108 | |
| (-) Preferred Stock | 0 | 0 | 0 | 0 | 0 | 0 | |
| (-) Other | 0 | 0 | 0 | 0 | 0 | 0 | |
| Value of Common Equity | 8,765 | 3,798 | 5,725 | 8,034 | 7,350 | 2,429 | |
| (/) Shares Outstanding | 1,365.3 | 254.9 | 323.1 | 1,261.3 | 1,427.1 | 498.8 | |
| Implied Stock Price | 6.42 | 14.90 | 17.72 | 6.37 | 5.15 | 4.87 | |
| FX Conversion Rate to Trading Currency | 1.00 | 1.00 | 1.00 | 1.00 | 1.00 | 1.00 | |
| Implied Stock Price (Trading Cur) | 6.42 | 14.90 | 17.72 | 6.37 | 5.15 | 4.87 | |
| Trading Currency | CNY | CNY | CNY | CNY | CNY | CNY | |
| FX Rate to Reporting Currency | 1.00 | 1.00 | 1.00 | 1.00 | 1.00 | 1.00 | |